nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLC15A1—Lisinopril—systemic scleroderma	0.213	0.246	CbGbCtD
Tolbutamide—SLC15A1—Captopril—systemic scleroderma	0.159	0.184	CbGbCtD
Tolbutamide—CYP2C8—Mometasone—systemic scleroderma	0.114	0.132	CbGbCtD
Tolbutamide—SLCO1A2—Prednisone—systemic scleroderma	0.0911	0.105	CbGbCtD
Tolbutamide—SLC22A6—Captopril—systemic scleroderma	0.0878	0.101	CbGbCtD
Tolbutamide—CYP2C9—Leflunomide—systemic scleroderma	0.0514	0.0593	CbGbCtD
Tolbutamide—SLCO1A2—Methotrexate—systemic scleroderma	0.0457	0.0528	CbGbCtD
Tolbutamide—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0455	0.0525	CbGbCtD
Tolbutamide—CYP2C19—Prednisone—systemic scleroderma	0.0305	0.0352	CbGbCtD
Tolbutamide—SLC22A6—Methotrexate—systemic scleroderma	0.0277	0.032	CbGbCtD
Tolbutamide—Reaction gastrointestinal—Azathioprine—systemic scleroderma	0.00664	0.0522	CcSEcCtD
Tolbutamide—Heartburn—Pentoxifylline—systemic scleroderma	0.00487	0.0383	CcSEcCtD
Tolbutamide—CYP2C9—cardial valve—systemic scleroderma	0.00325	0.517	CbGeAlD
Tolbutamide—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00315	0.0247	CcSEcCtD
Tolbutamide—Digestion impaired—Leflunomide—systemic scleroderma	0.00313	0.0246	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Lisinopril—systemic scleroderma	0.00309	0.0243	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Captopril—systemic scleroderma	0.00289	0.0227	CcSEcCtD
Tolbutamide—Reaction gastrointestinal—Methotrexate—systemic scleroderma	0.00267	0.021	CcSEcCtD
Tolbutamide—Heartburn—Lisinopril—systemic scleroderma	0.00261	0.0205	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.00252	0.0198	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.00227	0.0179	CcSEcCtD
Tolbutamide—Abdominal distension—Pentoxifylline—systemic scleroderma	0.00212	0.0166	CcSEcCtD
Tolbutamide—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00208	0.0164	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.00205	0.0161	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Captopril—systemic scleroderma	0.00204	0.0161	CcSEcCtD
Tolbutamide—Pancytopenia—Pentoxifylline—systemic scleroderma	0.002	0.0157	CcSEcCtD
Tolbutamide—Hyponatraemia—Captopril—systemic scleroderma	0.00185	0.0146	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00179	0.0141	CcSEcCtD
Tolbutamide—Pancytopenia—Captopril—systemic scleroderma	0.00151	0.0119	CcSEcCtD
Tolbutamide—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00148	0.0117	CcSEcCtD
Tolbutamide—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00148	0.0116	CcSEcCtD
Tolbutamide—Erythema—Pentoxifylline—systemic scleroderma	0.00146	0.0115	CcSEcCtD
Tolbutamide—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00146	0.0114	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Captopril—systemic scleroderma	0.00145	0.0114	CcSEcCtD
Tolbutamide—Eruption—Methotrexate—systemic scleroderma	0.00145	0.0114	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00145	0.0114	CcSEcCtD
Tolbutamide—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00134	0.0105	CcSEcCtD
Tolbutamide—Agranulocytosis—Captopril—systemic scleroderma	0.00133	0.0104	CcSEcCtD
Tolbutamide—Pancytopenia—Azathioprine—systemic scleroderma	0.00132	0.0104	CcSEcCtD
Tolbutamide—Leukopenia—Pentoxifylline—systemic scleroderma	0.00131	0.0103	CcSEcCtD
Tolbutamide—Hyponatraemia—Lisinopril—systemic scleroderma	0.00131	0.0103	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00996	CcSEcCtD
Tolbutamide—Abdominal distension—Mycophenolic acid—systemic scleroderma	0.00126	0.00992	CcSEcCtD
Tolbutamide—Pancytopenia—Leflunomide—systemic scleroderma	0.00125	0.00981	CcSEcCtD
Tolbutamide—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00119	0.00936	CcSEcCtD
Tolbutamide—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00922	CcSEcCtD
Tolbutamide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00117	0.0092	CcSEcCtD
Tolbutamide—Agranulocytosis—Azathioprine—systemic scleroderma	0.00116	0.0091	CcSEcCtD
Tolbutamide—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00903	CcSEcCtD
Tolbutamide—Agranulocytosis—Leflunomide—systemic scleroderma	0.00109	0.00859	CcSEcCtD
Tolbutamide—Pancytopenia—Lisinopril—systemic scleroderma	0.00107	0.00843	CcSEcCtD
Tolbutamide—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00105	0.00828	CcSEcCtD
Tolbutamide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00104	0.0082	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00103	0.0081	CcSEcCtD
Tolbutamide—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.000995	0.00783	CcSEcCtD
Tolbutamide—Urticaria—Pentoxifylline—systemic scleroderma	0.00095	0.00747	CcSEcCtD
Tolbutamide—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000939	0.00738	CcSEcCtD
Tolbutamide—Agranulocytosis—Lisinopril—systemic scleroderma	0.000939	0.00738	CcSEcCtD
Tolbutamide—Dyspepsia—Mometasone—systemic scleroderma	0.000908	0.00714	CcSEcCtD
Tolbutamide—Thrombocytopenia—Captopril—systemic scleroderma	0.000887	0.00698	CcSEcCtD
Tolbutamide—Leukopenia—Azathioprine—systemic scleroderma	0.000867	0.00682	CcSEcCtD
Tolbutamide—Pruritus—Pentoxifylline—systemic scleroderma	0.000846	0.00665	CcSEcCtD
Tolbutamide—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000838	0.00659	CcSEcCtD
Tolbutamide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000822	0.00647	CcSEcCtD
Tolbutamide—Leukopenia—Leflunomide—systemic scleroderma	0.000819	0.00644	CcSEcCtD
Tolbutamide—Dyspepsia—Captopril—systemic scleroderma	0.000797	0.00627	CcSEcCtD
Tolbutamide—Erythema—Lisinopril—systemic scleroderma	0.000786	0.00618	CcSEcCtD
Tolbutamide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000781	0.00614	CcSEcCtD
Tolbutamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000774	0.00609	CcSEcCtD
Tolbutamide—Rash—Pentoxifylline—systemic scleroderma	0.000754	0.00593	CcSEcCtD
Tolbutamide—Headache—Pentoxifylline—systemic scleroderma	0.000749	0.00589	CcSEcCtD
Tolbutamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000731	0.00575	CcSEcCtD
Tolbutamide—Pruritus—Mometasone—systemic scleroderma	0.00073	0.00574	CcSEcCtD
Tolbutamide—Nausea—Pentoxifylline—systemic scleroderma	0.00071	0.00558	CcSEcCtD
Tolbutamide—Leukopenia—Lisinopril—systemic scleroderma	0.000704	0.00553	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000697	0.00548	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000683	0.00537	CcSEcCtD
Tolbutamide—Abdominal distension—Prednisone—systemic scleroderma	0.000675	0.00531	CcSEcCtD
Tolbutamide—Dyspepsia—Leflunomide—systemic scleroderma	0.000657	0.00517	CcSEcCtD
Tolbutamide—Rash—Mometasone—systemic scleroderma	0.00065	0.00511	CcSEcCtD
Tolbutamide—Headache—Mometasone—systemic scleroderma	0.000646	0.00508	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000645	0.00507	CcSEcCtD
Tolbutamide—Pruritus—Captopril—systemic scleroderma	0.000641	0.00504	CcSEcCtD
Tolbutamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000628	0.00494	CcSEcCtD
Tolbutamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000627	0.00493	CcSEcCtD
Tolbutamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000617	0.00485	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000615	0.00484	CcSEcCtD
Tolbutamide—Nausea—Mometasone—systemic scleroderma	0.000613	0.00482	CcSEcCtD
Tolbutamide—Urticaria—Leflunomide—systemic scleroderma	0.000593	0.00466	CcSEcCtD
Tolbutamide—Rash—Captopril—systemic scleroderma	0.000571	0.00449	CcSEcCtD
Tolbutamide—Headache—Captopril—systemic scleroderma	0.000568	0.00446	CcSEcCtD
Tolbutamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000565	0.00444	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000554	0.00436	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00433	CcSEcCtD
Tolbutamide—Nausea—Captopril—systemic scleroderma	0.000538	0.00423	CcSEcCtD
Tolbutamide—Pancytopenia—Methotrexate—systemic scleroderma	0.000532	0.00418	CcSEcCtD
Tolbutamide—Pruritus—Leflunomide—systemic scleroderma	0.000528	0.00415	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000511	0.00402	CcSEcCtD
Tolbutamide—Urticaria—Lisinopril—systemic scleroderma	0.00051	0.00401	CcSEcCtD
Tolbutamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000504	0.00396	CcSEcCtD
Tolbutamide—Rash—Azathioprine—systemic scleroderma	0.000498	0.00392	CcSEcCtD
Tolbutamide—Headache—Azathioprine—systemic scleroderma	0.000495	0.0039	CcSEcCtD
Tolbutamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00389	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00382	CcSEcCtD
Tolbutamide—Rash—Leflunomide—systemic scleroderma	0.000471	0.0037	CcSEcCtD
Tolbutamide—Nausea—Azathioprine—systemic scleroderma	0.00047	0.00369	CcSEcCtD
Tolbutamide—Headache—Leflunomide—systemic scleroderma	0.000468	0.00368	CcSEcCtD
Tolbutamide—Erythema—Prednisone—systemic scleroderma	0.000467	0.00367	CcSEcCtD
Tolbutamide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000466	0.00366	CcSEcCtD
Tolbutamide—Pruritus—Lisinopril—systemic scleroderma	0.000454	0.00357	CcSEcCtD
Tolbutamide—Rash—Mycophenolic acid—systemic scleroderma	0.000449	0.00353	CcSEcCtD
Tolbutamide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00351	CcSEcCtD
Tolbutamide—Headache—Mycophenolic acid—systemic scleroderma	0.000446	0.00351	CcSEcCtD
Tolbutamide—Nausea—Leflunomide—systemic scleroderma	0.000443	0.00349	CcSEcCtD
Tolbutamide—CYP2C18—digestive system—systemic scleroderma	0.000426	0.0679	CbGeAlD
Tolbutamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000423	0.00333	CcSEcCtD
Tolbutamide—Rash—Lisinopril—systemic scleroderma	0.000405	0.00318	CcSEcCtD
Tolbutamide—Headache—Lisinopril—systemic scleroderma	0.000402	0.00316	CcSEcCtD
Tolbutamide—ABCC8—smooth muscle tissue—systemic scleroderma	0.000398	0.0634	CbGeAlD
Tolbutamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00313	CcSEcCtD
Tolbutamide—Erythema—Methotrexate—systemic scleroderma	0.00039	0.00307	CcSEcCtD
Tolbutamide—Nausea—Lisinopril—systemic scleroderma	0.000381	0.003	CcSEcCtD
Tolbutamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00279	CcSEcCtD
Tolbutamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000352	0.00277	CcSEcCtD
Tolbutamide—Leukopenia—Methotrexate—systemic scleroderma	0.000349	0.00275	CcSEcCtD
Tolbutamide—Dyspepsia—Prednisone—systemic scleroderma	0.000335	0.00264	CcSEcCtD
Tolbutamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00263	CcSEcCtD
Tolbutamide—KCNJ11—tendon—systemic scleroderma	0.000325	0.0517	CbGeAlD
Tolbutamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000312	0.00245	CcSEcCtD
Tolbutamide—Urticaria—Prednisone—systemic scleroderma	0.000303	0.00238	CcSEcCtD
Tolbutamide—SLC15A1—digestive system—systemic scleroderma	0.000301	0.0479	CbGeAlD
Tolbutamide—Dyspepsia—Methotrexate—systemic scleroderma	0.00028	0.0022	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000275	0.00216	CcSEcCtD
Tolbutamide—Pruritus—Prednisone—systemic scleroderma	0.00027	0.00212	CcSEcCtD
Tolbutamide—Urticaria—Methotrexate—systemic scleroderma	0.000253	0.00199	CcSEcCtD
Tolbutamide—SLCO2B1—digestive system—systemic scleroderma	0.000246	0.0392	CbGeAlD
Tolbutamide—Rash—Prednisone—systemic scleroderma	0.00024	0.00189	CcSEcCtD
Tolbutamide—Headache—Prednisone—systemic scleroderma	0.000239	0.00188	CcSEcCtD
Tolbutamide—SLCO2B1—tendon—systemic scleroderma	0.000234	0.0373	CbGeAlD
Tolbutamide—SLCO1A2—digestive system—systemic scleroderma	0.000226	0.0361	CbGeAlD
Tolbutamide—Nausea—Prednisone—systemic scleroderma	0.000226	0.00178	CcSEcCtD
Tolbutamide—Pruritus—Methotrexate—systemic scleroderma	0.000225	0.00177	CcSEcCtD
Tolbutamide—SLCO2B1—lung—systemic scleroderma	0.000206	0.0327	CbGeAlD
Tolbutamide—Rash—Methotrexate—systemic scleroderma	0.000201	0.00158	CcSEcCtD
Tolbutamide—Headache—Methotrexate—systemic scleroderma	0.000199	0.00157	CcSEcCtD
Tolbutamide—Nausea—Methotrexate—systemic scleroderma	0.000189	0.00149	CcSEcCtD
Tolbutamide—SLCO1A2—lung—systemic scleroderma	0.000189	0.0301	CbGeAlD
Tolbutamide—CYP2C19—digestive system—systemic scleroderma	0.000181	0.0289	CbGeAlD
Tolbutamide—SLC15A2—lung—systemic scleroderma	0.000157	0.025	CbGeAlD
Tolbutamide—CYP2C9—digestive system—systemic scleroderma	0.000141	0.0224	CbGeAlD
